Top

P&G to challenge Indian ban on Vicks Action 500 Extra

Vicks Action 500 Extra was banned by India's health ministry in a notice issued over the weekend.

Mumbai: US consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks.

Also Read: P&G stops sale of 'Vicks Action 500 Extra' after government ban

Procter & Gamble Hygiene and Health Care said that while it had stopped selling the product, it was evaluating all options to challenge the ban.

Also Read: Pfizer stops selling popular Corex cough syrup in India after ban

Vicks Action 500 Extra is a fixed-dose combination of paracetamol, phenylephrine and caffeine, which was banned by India's health ministry in a notice issued over the weekend.

Also Read: Delhi High Court grants Pfizer temporary relief on cough syrup ban

Also Read: India bans more than 300 combination drugs sold illegally

The product was one of 344 drug combinations, including several antibiotics and analgesics, that India ordered to be prohibited, saying that a government-appointed panel of experts had found the combinations lacked "therapeutic justification".

P&G said that all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy. It wasn't immediately clear how much the product contributed to P&G's sales.

( Source : reuters )
Next Story